[Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application].
Liapina. L A LA; Pastorova. V E VE; Obergan. T Iu TIu; Samonina. G E GE; Ashmarin. I P IP; Miasoedov. N F NF
Key Findings
- Regulatory proline‑rich peptides such as semax, selank, and glyprolines influence blood coagulation in distinct ways.
- The anticoagulant activity is linked to specific structural features of the peptides.
- Both natural and synthetic versions of these peptides have potential for practical medical applications to modulate hemostasis.
Practical Outcomes
- For biohackers, the research hints that semax and related peptides could affect clotting, but the study does not provide dosing guidelines or safety data for self‑administration. Until more detailed human trials are available, these findings are mainly of academic interest rather than a ready‑to‑use protocol.
Summary
The study looked at how certain small proteins called regulatory proline‑containing oligopeptides, including semax, affect blood clotting. It found that these peptides can have different anticoagulant (blood‑thinning) effects depending on their exact structure, suggesting they might be useful in medical settings that need to control clotting.
Abstract
Experimental and theoretical demonstration of different effect of certain regulatory peptides (RPs) on blood coagulation is available. The problem of the role of RPs in hemostatic processes becomes particularly significant since, first, the peptides are widespread in nature both in animal and plant tissues, second, there is a relationship between the peptide structure and function and, third, both natural and synthetic peptides are used in practical medicine to correct functions of some factors of the hemostatic system. Many peptide inhibitors of the primary and plasma hemostasis potentiating anticoagulant effects in the body have been described.
Study Information
pubmed
2006